Investigating which variables from the core outcome variables in juvenile idiopathic arthritis (JIA) are the best predictors of classification as a responder to treatment with methotrexate (MTX)

Ítems similars

• Investigating the use of a limited core outcome variable set for the classification of response following methotrexate treatment in juvenile idiopathic arthritis (JIA)
  per: Hirani, SP, et al.
  Publicat: (2008)
• Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study
  per: Mulligan, K, et al.
  Publicat: (2008)
• Mothers’ reports of the difficulties that their children experience in taking methotrexate for Juvenile Idiopathic Arthritis and how these impact on quality of life
  per: Mulligan, Kathleen, et al.
  Publicat: (2013)
• The experience of taking methotrexate for juvenile idiopathic arthritis: results of a cross-sectional survey with children and young people
  per: Mulligan, Kathleen, et al.
  Publicat: (2015)
• An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
  per: Livermore, P, et al.
  Publicat: (2008)